Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biospecifics Tech Cp (BSTC)

Biospecifics Tech Cp (BSTC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 393,905
  • Shares Outstanding, K 7,339
  • Annual Sales, $ 32,960 K
  • Annual Income, $ 20,050 K
  • 60-Month Beta 1.16
  • Price/Sales 11.87
  • Price/Cash Flow 17.26
  • Price/Book 3.32

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.94
  • Number of Estimates 1
  • High Estimate 0.94
  • Low Estimate 0.94
  • Prior Year 0.84
  • Growth Rate Est. (year over year) +11.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.81 +19.73%
on 10/24/19
54.90 -0.09%
on 11/20/19
+6.07 (+12.44%)
since 10/18/19
3-Month
45.81 +19.73%
on 10/24/19
59.41 -7.68%
on 09/16/19
-3.44 (-5.90%)
since 08/20/19
52-Week
45.81 +19.73%
on 10/24/19
73.31 -25.18%
on 02/19/19
-1.37 (-2.44%)
since 11/20/18

Most Recent Stories

More News
The Truth About Market Timing - November 14, 2019

In the long-run, does consistent market timing really matter to be a successful investor?

CMD : 72.77 (+0.58%)
TRXC : 0.26 (+4.00%)
BSTC : 53.59 (-0.15%)
CSBR : 5.74 (+10.38%)
RDNT : 18.04 (+2.62%)
BioSpecifics Technologies (BSTC) Q3 Earnings and Revenues Beat Estimates

BioSpecifics (BSTC) delivered earnings and revenue surprises of 13.33% and 6.57%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

BSTC : 53.59 (-0.15%)
BioSpecifics Reports Third Quarter 2019 Financial and Operating Results

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed...

BSTC : 53.59 (-0.15%)
BioSpecifics Technologies (BSTC) to Report Q3 Results: Wall Street Expects Earnings Growth

BioSpecifics (BSTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BSTC : 53.59 (-0.15%)
The Truth About Market Timing - October 24, 2019

In the long-run, does consistent market timing really matter to be a successful investor?

TRXC : 0.26 (+4.00%)
CMD : 72.77 (+0.58%)
CSBR : 5.74 (+10.38%)
BSTC : 53.59 (-0.15%)
RDNT : 18.04 (+2.62%)
Jennifer Chao Appointed Chairperson of BioSpecifics Technologies Corp. Board of Directors

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class product marketed as XIAFLEX® in the...

BSTC : 53.59 (-0.15%)
BioSpecifics (BSTC) Upgraded to Buy: Here's Why

BioSpecifics (BSTC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BSTC : 53.59 (-0.15%)
BioSpecifics Technologies Corp. Names J. Kevin Buchi as Chief Executive Officer

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed...

BSTC : 53.59 (-0.15%)
When Does Market Timing Actually Work? - October 03, 2019

Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?

BSTC : 53.59 (-0.15%)
TRXC : 0.26 (+4.00%)
CMD : 72.77 (+0.58%)
CSBR : 5.74 (+10.38%)
RDNT : 18.04 (+2.62%)
The Truth About Market Timing - September 13, 2019

Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?

CMD : 72.77 (+0.58%)
TRXC : 0.26 (+4.00%)
CSBR : 5.74 (+10.38%)
BSTC : 53.59 (-0.15%)
RDNT : 18.04 (+2.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade BSTC with:

Business Summary

BIOSPECIFICS TECHNOLOGIES is engaged in the business of producing and licensing, for sale by other, a U.S. Food and Drug Administration (``FDA``) approved enzyme derived from collagenase, named Collagenase ABC, and researching, developing and clinically testing additional products derived therefrom for...

See More

Key Turning Points

2nd Resistance Point 55.49
1st Resistance Point 54.58
Last Price 53.59
1st Support Level 52.93
2nd Support Level 52.19

See More

52-Week High 73.31
Fibonacci 61.8% 62.80
Fibonacci 50% 59.56
Fibonacci 38.2% 56.31
Last Price 53.59
52-Week Low 45.81

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar